Andrew Peller (ADW) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Apr, 2026Executive summary
Q3 2025 delivered strong year-over-year growth in revenue, margins, and EBITDA, driven by retail modernization in Ontario and successful big-box channel expansion, with revenue rising 5.2% to $105.4 million.
Net earnings reached $7.7 million in Q3 2025, reversing a net loss of $0.4 million in the prior year quarter.
Distribution points in Ontario expanded by over 4,000 locations, with big-box retail demand exceeding expectations and ongoing product lineup evolution.
Honest Lot emerged as the fastest-growing brand, reflecting consumer trends toward healthier-for-you products.
Working capital improvements and inventory right-sizing contributed to improved free cash flow and debt reduction.
Financial highlights
Q3 sales increased CAD 5.2 million (5.2% year-over-year) to CAD 105.4 million, mainly from big-box store sales and the Ontario VQA Support Program.
Q3 margin rose to CAD 42.4 million (up 22%), with margin as a percentage of sales at 40.2% versus 34.7% last year.
EBITDA for Q3 was CAD 18.5 million, up 40% from CAD 13.2 million last year; year-to-date EBITDA was CAD 49.4 million, up 20%.
Net earnings per Class A share for Q3 was $0.18 (vs. loss of $0.01); year-to-date: $0.28 (vs. $0.10).
Inventory decreased to CAD 167.9 million from CAD 192.5 million at fiscal 2024 year-end, with cash from operations at CAD 59.6 million year-to-date.
Outlook and guidance
Q4 is expected to be the lowest volume quarter, with some further balancing and modulation in big-box channel sales.
Margin expansion is anticipated next year, though seasonality and inflationary pressures remain.
Management is confident in outperforming the category through innovation and channel expansion.
Continued focus on cost savings, innovation, and adapting to evolving retail channels.
Latest events from Andrew Peller
- Q3 2026 delivered higher revenue, margins, and earnings, with strong growth and a positive outlook.ADW
Q3 202614 Apr 2026 - Q2 margin and earnings growth, cost savings, and retail gains drive a positive outlook.ADW
Q2 20268 Apr 2026 - Q1 EBITA rose 25%, margins expanded, and debt fell amid strong big box and western sales.ADW
Q1 20268 Apr 2026 - Q2 revenue and EBITDA rose on retail gains, but net earnings fell as costs increased.ADW
Q2 20258 Apr 2026 - Record margins and innovation in health-focused products drive growth and future opportunities.ADW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Margin and EBITDA growth, cost savings, and retail gains drive improved results and outlook.ADW
Q4 20243 Feb 2026 - EBITDA/EBITA grew to $12.9M despite a 1% sales drop, driven by cost savings and efficiency.ADW
Q1 20252 Feb 2026 - Net earnings rebounded to $11.1M on record revenue, margin gains, and lower debt.ADW
Q4 202513 Nov 2025 - Double-digit EBITA growth and margin expansion drive renewed profitability and long-term value.ADW
Investor Presentation2 Jul 2025